Clinical Trials Logo

Filter by:
NCT ID: NCT06242366 Recruiting - Ischemic Stroke Clinical Trials

Transitional Care Program in Stroke Patients With Hemiplegia.

Start date: February 7, 2024
Phase: N/A
Study type: Interventional

This study examines the effects of a transitional care program in stroke patients on self-care behavior, quality of life, and hospital readmission. The research conceptual framework is based on the Transitional Care Model by Naylor. Sixty participants with stroke patients at Charoenkrung Pracharak Hospital will be recruited. These participants are stratified by block randomization using NIHSS score and divided into 2 groups; a control group (n=30) and an intervention group (n=30). The program consisted of 2 phases: 1) Phase I during hospital admission and 2) Phase II following hospital discharge

NCT ID: NCT06242236 Recruiting - ARDS Clinical Trials

Comparison of Guiding Sedation Level by Respiratory Effort Versus Usual Care in Mechanically Ventilated Patients: A Randomized Controlled Trial (EFFORT-GUIDE Trial 2)

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

The objective of this research is to utilize respiratory effort parameters as a tool to assist in adjusting sedative drug levels for patients undergoing mechanical ventilation in the intensive care unit, in comparison to the conventional usual care approach.

NCT ID: NCT06239259 Recruiting - Clinical trials for Carpal Tunnel Syndrome

Validity and Reliability of Thai Version Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome

Start date: July 6, 2023
Phase:
Study type: Observational

The Kamath and Stothard clinical questionnaire for diagnosing carpal tunnel syndrome (CTS) is a valid score for diagnosis of CTS. However it haven't been translated in to Thai version and the validity and accuracy of the Thai the Thai version have not been yet verified. The research team recognizes the importance and potential benefits of adapting this assessment for use within the Thai population.Therefore, we aim to conduct this research to translate the questionnaire from the original English to Thai and to assess its validity and reliability for diagnosing patients with Carpal Tunnel Syndrome.

NCT ID: NCT06236646 Recruiting - Clinical trials for Mild Cognitive Impairment

Effects of Thai Dance With Twenty-five Squares in Elderly With Mild Cognitive Impairment

Start date: January 3, 2024
Phase: N/A
Study type: Interventional

The objective of this study was to determine the effects of Thai dance with twenty-five squares on cerebrovascular and cognitive function in elderly with mild cognitive impairment

NCT ID: NCT06236074 Recruiting - Clinical trials for Laparoscopic Cholecystectomy

Comparison of Modified Post-Anesthetic Discharge Scoring System (PADSS) Between 4 and 24 Hours in Patients Undergoing Laparoscopic Cholecystectomy

Start date: January 24, 2024
Phase: N/A
Study type: Interventional

This study is compare of Modified Post-Anesthetic Discharge Scoring System (PADSS) between 4 and 24 hours in patients undergoing laparoscopic cholecystectomy

NCT ID: NCT06234540 Recruiting - Thin Endometrium Clinical Trials

a-PRP Intrauterine Instillation in Women With Thin Endometrium

PRP(a-PRP)
Start date: January 21, 2024
Phase: N/A
Study type: Interventional

This study sought to compare the endometrial thickness among infertile women with a history of thin endometrium together with previous cancellation from IVF/ICSI inspection of intrauterine instillation of autologous-PRP or no treatment before embryo transfer in the frozen-thaw cycles.

NCT ID: NCT06233435 Recruiting - Clinical trials for Total Knee Arthroplasty

Comparison of Modified Post-Anesthetic Discharge Scoring System (PADSS) Between 6 and 24 Hours in Patients Undergoing Total Knee Arthroplasty

Start date: January 24, 2023
Phase: N/A
Study type: Interventional

This study is a prospective study which compares of Modified Post-Anesthetic Discharge Scoring System (PADSS) between 6 and 24 hours in patients undergoing total knee arthroplasty in Thammasat University hospital, Thailand.

NCT ID: NCT06233071 Recruiting - Healthy Subjects Clinical Trials

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Start date: February 13, 2024
Phase: Phase 1
Study type: Interventional

The study is to compare the rate and extent of absorption of a generic formulation with that of a reference for mulation when given as equal labeled dose. The study will be randomized, open-label, single dose, two way crossover design with two-period, two-treatment and two-sequence under fasting condition and at least 28 days washout period between the doses.

NCT ID: NCT06231914 Recruiting - Laxity; Skin Clinical Trials

Efficacy and Safety of Fractional 1064-nm Picosecond Laser for Facial Skin Tightening

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn the efficacy and safety of fractional 1064-nm picosecond laser for facial skin tightening. The main questions it aims to answer are: - Efficacy of fractional 1064-nm picosecond laser for facial skin efficacy including the changes in wrinkle, nasolabial fold, skin laxity, and skin elasticity - The changes in texture and pore volume using Antera - The changes in bioengineering assessment: melanin index, erythema index, sebum level - Adverse events Participants will be treated with 3 sessions of fractional 1064-nm picosecond laser (full face 4 passes, vector lines 4 passes), spaced 4 weeks apart. Follow-up visits 1, 3, and 6 months after the last treatments.

NCT ID: NCT06230224 Recruiting - Clinical trials for B-Cell Non-Hodgkin Lymphoma (B-NHL)

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma

OLYMPIA-4
Start date: February 15, 2024
Phase: Phase 3
Study type: Interventional

The study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on patients with previously treated aggressive B-cell non-Hodgkin lymphoma whose cancer has stopped responding to treatment (also known as 'refractory') or has returned (also known as 'relapsed'). The aim of the study is to see how effective the study drug is compared to standard of care (SOC) therapy. The study is looking at several other research questions, including: - What side effects may happen from taking the study drug versus SOC - How much study drug is in your blood at different times - Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects) - Comparing the impact from the study drug versus SOC on your quality-of-life and ability to complete routine daily activities